Year 2015 Vol. 23 No 2

REVIEWS

V.M. BONDARENKO 1, N.I. DOSTA 2, A.A. ZHEBENTYAEV 1

SOME PATHOGENETIC ASPECTS OF ERECTILE DYSFUNCTION

EE "Vitebsk State Medical University"1,
SEE "Belarusian Medical Academy of Post-Graduate Education"2,
The Republic of Belarus

Objectives. To generalize and to systematize the available literature data concerning pathogenetical mechanisms of the erectile dysfunction development that is thought to be a basis for a choice of treatment methods and recommendations for patients suffering from the given problem.
Methods. PubMed database was used to prepare the review (2004-2014 yrs) and an analysis of the main types of publications (original articles, randomized studies, reviews, meta-analyzes, recommendations, consensus).
Results. Previous research has found a high prevalence of metabolic syndrome (MS) and diabetes mellitus among patients with erectile dysfunction as well as the similarity of original causes of erectile dysfunction (ED) and cardiovascular disease (CVD). MS is a complex of risk factors that appears to be determined as potentially dangerous for endothelial dysfunction development resulting in CVD and ED. The adipocytes of the visceral adipose tissue functionate as endocrine cells producing and secreting adipokines as well as a number of biochemical modulators and proinflammatory factors affecting the vascular inflammation that is thought to contribute ED development. ED treatment in patients with MS should be complex and except a specific therapy it should include prompt diagnosis as well as adequate and active treatment of any risk factors that may be revealed.
Conclusion. In the pathogenesis of erectile dysfunction of vascular genesis a key role plays the combination of risk factors that lead to pathological changes of vascular endothelial function and impaired penile blood flow.
In addition to already established and well-known factors, a negative impact of perivisceral adipose tissue may be important and thereby requires further study.

Keywords: erectile dysfunction, visceral adipose tissue, testosterone, metabolic syndrome, adipocytes, endothelial function, prompt diagnosis.
p. 217-225 of the original issue
References
  1. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E. European Association of Urology.Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010 May;57(5):804-14. doi: 10.1016/j.eururo.2010.02.020.
  2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994 Jan;151(1):54-61.
  3. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M; Men's Attitudes to Life Events and Sexuality (MALES) Study.The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004 May;20(5):607-17.
  4. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007 Feb;120(2):151-7.
  5. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O'Leary MP, Puppo P, Robertson C, Giuliano F.Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003 Dec;44(6):637-49.
  6. Celik O, Ipekci T, Akarken I, Ekin G, Koksal T. To evaluate the etiology of erectile dysfunction: What should we know currently? Arch Ital Urol Androl. 2014 Sep 30;86(3):197-201. doi: 10.4081/aiua.2014.3.197.
  7. Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M.The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract. 2008 May;62(5):791-8. doi: 10.1111/j.1742-1241.2008.01696.x.
  8. Moore CS, Grant MD, Zink TA, Panizzon MS, Franz CE, Logue MW, Hauger RL, Kremen WS, Lyons MJ.Erectile dysfunction, vascular risk, and cognitive performance in late middle age. Psychol Aging. 2014 Mar;29(1):163-72. doi: 10.1037/a0035463.
  9. Schwartz BG, Kloner RA.Cardiology patient page: cardiovascular implications of erectile dysfunction. Circulation. 2011 May 31;123(21):e609-11. doi: 10.1161/CIRCULATIONAHA.110.017681.
  10. Nicolai MP, van Bavel J, Somsen GA, de Grooth GJ, Tulevski II, Lorsheyd A, Putter H, Schalij MJ, Pelger RC, Elzevier HW. Erectile dysfunction in the cardiology practice-a patients' perspective. Am Heart J. 2014 Feb;167(2):178-85. doi: 10.1016/j.ahj.2013.10.021.
  11. Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, de la Taille A, Hayek OR, Shabsigh R. Hypertension is associated with severe erectile dysfunction. J Urol. 2000 Oct;164(4):1188-91.
  12. Lewis RW.Epidemiology of erectile dysfunction. Urol Clin North Am. 2001 May;28(2):209-16, vii.
  13. Borges R, Temido P, Sousa L, Azinhais P, Conceição P, Pereira B, Leão R, Retroz E, Brandão A, Cristo L, Sobral F.Metabolic syndrome and sexual (dys)function. J Sex Med. 2009 Nov;6(11):2958-75. doi: 10.1111/j.1743-6109.2009.01412.x.
  14. Nusbaum MR. Erectile dysfunction: prevalence, etiology, and major risk factors. J Am Osteopath Assoc. 2002 Dec;102(12 Suppl 4):S1-6.
  15. Fonseca V, Jawa A.Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome: common pathways and treatments? Am J Cardiol. 2005 Dec 26;96(12B):13M-18M.
  16. Rekomendatsii ekspertov vserossiiskogo nauchnogo obshchestva kardiologov po diagnostike i lecheniiu metabolicheskogo sindroma [Recommendations of experts national Society of Cardiology for the diagnosis and treatment of metabolic syndrome] (Vtoroi peresmotr). Moscow, RF: 2009. 32 p.
  17. Müller A, Mulhall JP.Cardiovascular disease, metabolic syndrome and erectile dysfunction. Curr Opin Urol. 2006 Nov;16(6):435-43.
  18. Caballero B.The global epidemic of obesity: an overview. Epidemiol Rev. 2007;29:1-5.
  19. Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A, Balercia G, Chiarini V, Forti G, Maggi M. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol. 2006 Sep;50(3):595-604; discussion 604
  20. Gündüz MI, Gümüs BH, Sekuri C.Relationship between metabolic syndrome and erectile dysfunction. Asian J Androl. 2004 Dec;6(4):355-8.
  21. Esposito K, Giugliano F, Martedì E, Feola G, Marfella R, D'Armiento M, Giugliano D.High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care. 2005 May;28(5):1201-3.
  22. Heidler S, Temml C, Broessner C, Mock K, Rauchenwald M, Madersbacher S, Ponholzer A.Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol. 2007 Feb;177(2):651-4.
  23. Demir T, Demir O, Kefi A, Comlekci A, Yesil S, Esen A. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol. 2006 Apr;13(4):385-88.
  24. Bal K, Oder M, Sahin AS, Karataş CT, Demir O, Can E, Gümüş BH, Ozer K, Sahin O, Esen AA. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology. 2007 Feb;69(2):356-60.
  25. Corona G, Mannucci E, Forti G, Maggi M.Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. Int J Androl. 2009 Dec;32(6):587-98. doi: 10.1111/j.1365-2605.2008.00951.x.
  26. Stehouwer CD, Henry RM, Ferreira I.Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008 Apr;51(4):527-39. doi: 10.1007/s00125-007-0918-3.
  27. Kaplan SA, Meehan AG, Shah A.The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol. 2006 Oct;176(4 Pt 1):1524-27; discussion 1527-28.
  28. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006 Mar;91(3):843-50.
  29. Chubb SA, Hyde Z, Almeida OP, et al. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: The Health in Men Study. Eur J Endocrinol. 2008 Jun;158(6):785-92. doi: 10.1530/EJE-07-0893.
  30. Larsen SH, Wagner G, Heitmann BL. Sexual function and obesity. Int J Obes (Lond). 2007 Aug;31(8):1189-98.
  31. Zumoff B. Hormonal abnormalities in obesity. Acta Med Scand Suppl. 1988;723:153-60.
  32. Loves S, Ruinemans-Koerts J, de Boer H.Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism. Eur J Endocrinol. 2008 May;158(5):741-7. doi: 10.1530/EJE-07-0663.
  33. Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D, Hayes FJ.Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab. 2005 May;90(5):2636-41.
  34. Burcelin R, Thorens B, Glauser M, Gaillard RC, Pralong FP.Gonadotropin-releasing hormone secretion from hypothalamic neurons: stimulation by insulin and potentiation by leptin. Endocrinology. 2003 Oct;144(10):4484-91.
  35. Bansal TC, Guay AT, Jacobson J, Woods BO, Nesto RW.Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction. J Sex Med. 2005 Jan;2(1):96-103.
  36. Yassin AA, Saad F, Gooren LJ. Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone. Andrologia. 2008 Aug;40(4):259-64. doi: 10.1111/j.1439-0272.2008.00851.x.
  37. Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013 Jan;93(1):359-404. doi: 10.1152/physrev.00033.2011.
  38. Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F.The concept of normal weight obesity. Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):426-33. doi: 10.1016/j.pcad.2013.10.003.
  39. Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG.Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord. 2004 Dec;28 Suppl 4:S58-65.
  40. Bondarenko VM, Pimanov SI, Dosta NI. Korreliatsiia urovnia testosterona v syvorotke krovi s kolichestvom vistseral'noi zhirovoi tkani [Correlation between the level of testosterone in the blood serum with the amount of visceral adipose tissue]. Vestn VGMU. 2014;13(1):98-103.
  41. Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci. 2009 Sep;54(9):1847-56. doi: 10.1007/s10620-008-0585-3.
  42. Traish AM, Feeley RJ, Guay A. Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction. FEBS J. 2009 Oct;276(20):5755-67. doi: 10.1111/j.1742-4658.2009.07305.x.
  43. Lyon CJ, Law RE, Hsueh WA.Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003 Jun;144(6):2195-200.
  44. Sowers JR.Endocrine functions of adipose tissue: focus on adiponectin. Clin Cornerstone. 2008;9(1):32-38; discussion 39-40.
  45. Pietiläinen KH, Kannisto K, Korsheninnikova E, Rissanen A, Kaprio J, Ehrenborg E, Hamsten A, Yki-Järvinen H. Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins. J Clin Endocrinol Metab. 2006 Jul;91(7):2776-81.
  46. Hawley JA, Lessard SJ. Exercise training-induced improvements in insulin action. Acta Physiol (Oxf). 2008 Jan;192(1):127-35. doi: 10.1111/j.1748-1716.2007.01783.x.
  47. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004 Jun 23;291(24):2978-84.
Address for correspondence:
210023, Respublika Belarus,
g. Vitebsk, pr. Frunze, d. 27, Usch
"Vitebskiy gosudarstvennyiy meditsinskiy universitet",
kafedra gospitalnoy khirurgii s kursami urologii i detskoy khirurgii
tel. office: 375 212 582436,
e-mail: bondarenko_v@tut.by,
Bondarenko Vladimir Mihaylovich
Information about the authors:
Bondarenko V.M. An assistant of the hospital surgery chair with the course of urology and pediatric surgery of EE "Vitebsk State Medical University".
Dosta N. I. PhD, an associate professor of the urology chair of SBE "Belarusian Medical Academy of Post-graduate Education".
Zhebentyaev A.A. PhD, an associate professor of the hospital surgery chair with the course of urology and pediatric surgery of EE "Vitebsk State Medical University".
Contacts | ©Vitebsk State Medical University, 2007-2023